![Gwendolyn Binder-Scholl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 118 359 $ au 31/05/2026
Gwendolyn Binder-Scholl is currently an Independent Director at Instil Bio, Inc. since 2020 and President-Science & Technology at Cabaletta Bio, Inc. since 2022.
Former positions include Director-Scientific Affairs at VIRxSYS Corp.
from 2002 to 2005, Director-Translational Research Operations at the University of Pennsylvania from 2006 to 2011, Executive Vice President at Adaptimmune LLC, and Chief Technology Officer at Adaptimmune Therapeutics Plc from 2016 to 2019.
Education includes a doctorate from The Johns Hopkins University conferred in 2002 and undergraduate studies at Wells College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CABALETTA BIO, INC. 0,03% | 10/04/2026 | 31 312 ( 0,03% ) | 118 359 $ | 31/05/2026 |
INSTIL BIO, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CABALETTA BIO, INC. | Directeur Technique/Scientifique/R&D | 01/02/2019 |
| INSTIL BIO, INC. | Directeur/Membre du Conseil | 01/07/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 31/01/2019 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2011 |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Corporate Officer/Principal | 01/01/2005 |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious disease | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wells College
 Wells College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune LLC
Adaptimmune LLC Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious disease | Health Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Cabaletta Bio, Inc.
 Cabaletta Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which discovers and develops engineered cell therapies for B cell-mediated autoimmune diseases | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
